5
1

A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.

4/17/2026, 2:15 PM

Summary of Bill S 4332

This bill, introduced in the 119th Congress as S.4332 on April 16, 2026, aims to mandate the Secretary of Health and Human Services to assess the exclusivity periods applicable to licensed biological products, specifying the eligibility criteria for such periods.

Current Status of Bill S 4332

Bill S 4332 is currently in the status of Bill Introduced since April 16, 2026. Bill S 4332 was introduced during Congress 119 and was introduced to the Senate on April 16, 2026.  Bill S 4332's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of April 16, 2026

Bipartisan Support of Bill S 4332

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 4332

Primary Policy Focus

Alternate Title(s) of Bill S 4332

A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.
A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.

Comments